Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15615
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 18, 2018
Authors
Publisher
Wiley